Here are three things to know.
1. The FDA approved the drug under the President’s Emergency Plan for AIDS Relief, a federal initiative to combat the global HIV/AIDS epidemic.
2. TLE400 will be used as a first-line treatment regimen for HIV/AIDS patients in developing countries.
3. The World Health Organization recommended the drug as an alternative first-line treatment for HIV-positive adults in 2016.
More articles on supply chain:
96% of older Americans want Medicare to negotiate drug costs: 4 survey findings
FDA granted 99% of applications for access to unapproved drugs in FY 2016
FDA warns of safety risks with Abbott’s dissolving stent: 5 takeaways
